Literature DB >> 29149146

Dexamethasone and Dexmedetomidine as an Adjuvant to Intraarticular Bupivacaine for Postoperative Pain Relief in Knee Arthroscopic Surgery: A Randomized Trial.

Seham M Moeen1, Islam K Ramadan2, Hesham A Elkady2.   

Abstract

BACKGROUND: Knee arthroscopy causes minimal trauma, however, good analgesia is required for early rehabilitation and return to normal life in the patients.
OBJECTIVE: We aimed to compare the analgesic effects of intraarticular dexamethasone and dexmedetomidine added to bupivacaine with those of bupivacaine alone. STUDY
DESIGN: This study uses a double-blind, randomized, controlled design with allocation concealment in a 3-armed parallel group format among patients undergoing arthroscopic meniscal surgery.
SETTING: The study was conducted at Assiut University Hospital in Asyut, Egypt. The study duration was from July 2016 to February 2017.
METHODS: After the ethics committee approval, 60 patients, with the American Society of Anesthesiologists (ASA) physical status of I or II, 20 - 50 years old, and scheduled for arthroscopic meniscal surgery were randomized in a double-blind manner to receive 18 mL intraarticular bupivacaine 0.25% with either dexamethasone 8 mg (group I), dexmedetomidine 1 ug/kg (group II), or 2 mL of normal saline (group III). The total volume of injectate used in each group was 20 mL. All of the patients received spinal anesthesia. Postoperatively, oral paracetamol 1000 mg was given every 8 hours, and oral tramadol 50 mg was administered, as needed, for rescue analgesia. The visual analog scale (VAS) pain scores, time to first analgesic request, and total dose of postoperative analgesics were recorded for 3 days postoperatively.
RESULTS: The VAS scores were lower in groups I and II compared with group III. The time to the first analgesic was significantly shorter in group III compared with groups I and II (P = 0.001). The total dose of rescue paracetamol was higher in group III compared with groups I and II (P = 0.001). No need for tramadol rescue analgesia was recorded in any of the groups. No significant differences between groups I and II were noticed. LIMITATIONS: The limitations of this study include the lack of previous research to compare the effect of both intraarticular dexamethasone and dexmedetomidine added to bupivacaine for postoperative analgesia in arthroscopic knee surgery. Additionally, there was a short observation period for the detection of chondrotoxicity, if occurred.
CONCLUSION: The addition of dexamethasone or dexmedetomidine to a solution of bupivacaine 0.25% provided better analgesia than using bupivacaine alone. CLINICAL TRIAL REGISTRATION: NCT02818985. KEY WORDS: Intraarticular, knee arthroscopy, bupivacaine, dexmedetomidine, dexamethasone, postoperative pain.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29149146

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  10 in total

Review 1.  Orthopaedic publications from Egypt in the last five years: a bibliometric report.

Authors:  Hatem G Said; Mohamed Abd El-Radi; Mohamed Y Hassanein; Galal Z Said
Journal:  Int Orthop       Date:  2018-09-18       Impact factor: 3.075

2.  Comparison of intraarticular bupivacaine-dexmedetomidine and bupivacaine-magnesium sulfate for postoperative analgesia in arthroscopic meniscectomy: a randomized controlled clinical trial.

Authors:  H G Aytuluk; A Gultekin; K T Saracoglu
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

3.  Superior Block Length and Reduced Opioid Use with Dexmedetomidine and Dexamethasone regional block versus plain Ropivacaine: a retrospective trial.

Authors:  Amnon A Berger; Zuby Syed; Lianne Ryan; Christopher Lee; Jamal Hasoon; Ivan Urits; Omar Viswanath; Elyse M Cornett; Alan D Kaye; Jonathan P Eskander
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

4.  Effect of Intra-articular Dexmedetomidine on Postoperative Pain after Knee Arthroscopic Surgery.

Authors:  Sholeh Nesioonpour; Ahmad Reza Mohtadi; Ali Ghomeishi; Mohsen Savaie; Hooman Pedram; Sara Poursalehan; Yasaman Esfahanian
Journal:  Arch Bone Jt Surg       Date:  2022-03

5.  Pain Alleviation and Opioid Weaning in an 80-Year-Old with Chronic Foot Pain Following Injection Therapy with Perineural Dexmedetomidine and Dexamethasone.

Authors:  Amnon A Berger; Ivan Urits; Jamal Hasoon; Alan D Kaye; Omar Viswanath; Jonathan Eskander
Journal:  Surg J (N Y)       Date:  2021-01-07

6.  Dexamethasone Does not Compensate for Local Anesthetic Cytotoxic Effects on Tenocytes: Morphine or Morphine Plus Dexamethasone May Be a Safe Alternative.

Authors:  Anne Lene Oeyen; Jörn Kircher; Melanie Vogl; Irina Ickert; Nani Osada; Rüdiger Krauspe; Bernd Bittersohl; Monika Herten
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-12-23

7.  The efficacy and safety of multiple versus single doses dexamethasone in unicompartmental knee arthroplasty: A protocol of randomized controlled trial.

Authors:  Dehong Gao; Xin Liu; Fan Zhang; Mingyan Ding
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.889

8.  Comparison of Efficacy of Intra-Articular Plain Bupivacaine and Bupivacaine with Adjuvants (Dexmedetomidine and Magnesium Sulfate) for Postoperative Analgesia in Arthroscopic Knee Surgeries: A Prospective, Randomized Controlled Trial.

Authors:  M Manjula Devi; Surbhi Gupta; Rajkumar Amaravathi; Sahana Udupa; Ajey Hegde; Santu Ghosh
Journal:  Anesth Essays Res       Date:  2018 Oct-Dec

9.  The efficacy of dexamethasone on pain management for knee arthroscopy: A meta-analysis of randomized controlled trials.

Authors:  Chuangang Peng; Chen Li; Baoming Yuan; Jianhang Jiao
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

10.  Partial Medial Meniscectomy Using Needle Arthroscopy and a Standardized Local Anesthetic Protocol.

Authors:  Matt Daggett; Tyler Tucker; Edoardo Monaco; Andrea Redler; Johnathan Pettegrew; Giorgio Bruni; Adnan Saithna
Journal:  Arthrosc Tech       Date:  2020-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.